secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0000950170-24-095486
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma appoints Sukhi Jagpal to Board of Directors and Audit Committee
-------------------------------------------------------------------------------

- Sukhi Jagpal appointed as Class III director effective August 8, 2024, and to Audit Committee effective August 15, 2024.
- Jagpal receives pro rata portions of $40,000 director retainer and $10,000 Audit Committee retainer for remainder of year.
- Granted stock options: 35,000 shares (3-year monthly vest) and 28,959 shares (vesting until 2025 annual meeting).
- Standard indemnification agreement entered; no family relationships or material transactions with existing officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024095486/0000950170-24-095486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024095486/stro-20240808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-095486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer